ArticleCPT: pharmacometrics & systems pharmacology2025
QPRapp: A Web-Based Platform for PK/PD Simulations and Early Feasibility Analysis.
Article in CPT: pharmacometrics & systems pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quantitative pharmacology research application (QPRapp) is a web-based, interactive, and easy to use Shiny for Python interface, which facilitates evaluation of dose-exposure relationships, pharmacokinetic/pharmacodynamic (PK/PD) assessment of small and large molecules, and calculation of target occupancy for mono-, bi-, and tri-specific molecules. The dashboard sidebar offers a streamlined approach that incorporates multiple inputs, with various drop-down options to conduct respective simulations. The user can specify the type of molecule (small or large), number of model's compartments (one or two), and for large molecules, the number of drug's targets (one, two, or three). Additionally, the user can choose among the four indirect response PD models and execute the corresponding PK/PD simulations for small molecules. The platform application allows users to easily export simulated scenarios as CSV files for further analysis. Boasting features such as target-mediated drug disposition (TMDD) and early feasibility analysis (EFA) for multi-specific molecules, this application can assist project teams with limited computational expertise in applying model-informed drug development (MIDD) during the early stages of drug discovery and development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.